Brazil scraps Covaxin Application for Authorisation as Former Partner Attacks Bharat Biotech
July 25, 2021 13:40Indian pharmaceutical giant Bharat Biotech’s ambitious plans to sell millions of doses of its highly-priced vaccine, Covaxin, to Brazil all but crashed on Saturday after the National Health Surveillance Agency (ANVISA) decided to scrap the company’s application for emergency use authorisation (EUA) In a unanimous decision, the executive board of the Brazilian regulator declared that […]
